APG Asset Management N.V. raised its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 1,010.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 174,858 shares of the medical research company's stock after purchasing an additional 159,117 shares during the quarter. APG Asset Management N.V. owned about 0.06% of Agilent Technologies worth $22,685,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of A. Arete Wealth Advisors LLC purchased a new position in Agilent Technologies in the 3rd quarter valued at about $215,000. Orion Portfolio Solutions LLC grew its stake in Agilent Technologies by 9.0% during the 3rd quarter. Orion Portfolio Solutions LLC now owns 8,513 shares of the medical research company's stock valued at $1,264,000 after purchasing an additional 704 shares in the last quarter. MML Investors Services LLC increased its holdings in Agilent Technologies by 3.2% during the 3rd quarter. MML Investors Services LLC now owns 43,205 shares of the medical research company's stock worth $6,415,000 after purchasing an additional 1,337 shares during the last quarter. Y Intercept Hong Kong Ltd raised its position in shares of Agilent Technologies by 82.3% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 9,986 shares of the medical research company's stock valued at $1,483,000 after purchasing an additional 4,507 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. grew its position in shares of Agilent Technologies by 4.7% during the third quarter. Nomura Asset Management Co. Ltd. now owns 85,436 shares of the medical research company's stock worth $12,686,000 after buying an additional 3,843 shares in the last quarter.
Agilent Technologies Stock Performance
Shares of Agilent Technologies stock traded down $2.11 during trading on Tuesday, hitting $103.08. 354,093 shares of the stock were exchanged, compared to its average volume of 1,852,905. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $155.35. The stock's fifty day moving average is $122.90 and its 200 day moving average is $133.54. The stock has a market cap of $29.39 billion, a PE ratio of 23.70, a P/E/G ratio of 2.89 and a beta of 1.19.
Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The company had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.55 EPS for the current year.
Agilent Technologies Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be issued a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.96%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies's payout ratio is currently 22.76%.
Insider Activity at Agilent Technologies
In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the transaction, the director now directly owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. This trade represents a 4.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the sale, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This represents a 8.05 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,638 shares of company stock worth $731,229 in the last 90 days.
Wall Street Analyst Weigh In
A has been the topic of several recent analyst reports. Robert W. Baird cut their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a report on Thursday, February 27th. TD Cowen increased their price target on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. Barclays lowered their price objective on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. StockNews.com raised Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Finally, Citigroup lifted their target price on Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research report on Thursday, December 19th. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $146.25.
Check Out Our Latest Stock Report on A
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
See Also
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
